Evidence map›Paper›PMID 37800450›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2024

Gene-specific ACMG/AMP classification criteria for germline APC variants: Recommendations from the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel.

Isabel Spier, Xiaoyu Yin, Marcy Richardson, Marta Pineda, Andreas Laner, Deborah Ritter, Julie Boyle, Pilar Mur, Thomas V O Hansen, Xuemei Shi and 23 more

Open access · hybridAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. An accurate cellular assay to determine pathogenicity of coding and noncoding variants in Lynch syndrome genes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Article
  11. Article
  12. Frequent Detection ofHuman mutation · 2026
    Article
  13. The Performance ofHuman mutation · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 20 institutions in 12 countries.

Isabel SpierInstitute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany; European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS) - Project ID No 739547.
Xiaoyu YinInstitute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany; Department of Colorectal Medicine and Genetics, Royal Melbourne Hospital, Parkville, Australia; Department of Medicine, University of Melbourne, Parkville, Australia. Electronic address: xiaoyu.yin@mh.org.au.
Marcy RichardsonAmbry Genetics, Aliso Viejo, CA.
Marta PinedaEuropean Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS) - Project ID No 739547; Hereditary Cancer Program, Catalan Institute of Oncology - ONCOBELL, IDIBELL, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.
Andreas LanerMedical Genetics Center Munich, MGZ Munich, Germany.
Deborah RitterBaylor College of Medicine, Houston, TX; Texas Children's Cancer Center, Texas Children's Hospital, Houston, TX.
Julie BoyleDepartment of Oncological Sciences, School of Medicine, University of Utah, Salt Lake City, UT.
Pilar MurHereditary Cancer Program, Catalan Institute of Oncology - ONCOBELL, IDIBELL, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.
Thomas V O HansenDepartment of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Xuemei ShiGreenwood Genetic Center, Greenwood, SC.
Khalid MahmoodColorectal Oncogenomics Group, Department of Clinical Pathology, University of Melbourne, Parkville, Australia; Melbourne Bioinformatics, University of Melbourne, Parkville, Australia.
John-Paul PlazzerDepartment of Colorectal Medicine and Genetics, Royal Melbourne Hospital, Parkville, Australia.
Elisabet OgnedalHaukeland University Hospital, Bergen, Norway.
Margareta NordlingDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; Department of Clinical Genetics, Linköping University Hospital, Linköping, Sweden.
Susan M FarringtonCancer Research UK Edinburgh Centre, the University of Edinburgh, Edinburgh, United Kingdom.
Gou YamamotoDepartment of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, Saitama, Japan.
Stéphanie Baert-DesurmontDepartment of Genetics, Rouen University Hospital, Rouen, France.
Alexandra MartinsDepartment of Genetics, Rouen University Hospital, Rouen, France.
Ester BorrasInvitae, San Francisco, CA.
Carli TopsDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Erica WebbGeneDx, Gaithersburg, MD.
Victoria BeshayPeter MacCallum Cancer Centre, Melbourne, Australia.
Maurizio GenuardiFondazione Policlinico Universitario A. Gemelli IRCCS, and Dipartimento di Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy.
Tina PesaranAmbry Genetics, Aliso Viejo, CA.
Gabriel CapelláEuropean Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS) - Project ID No 739547; Hereditary Cancer Program, Catalan Institute of Oncology - ONCOBELL, IDIBELL, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.
Sean V TavtigianDepartment of Oncological Sciences, School of Medicine, University of Utah, Salt Lake City, UT; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
Andrew LatchfordPolyposis Registry, St. Mark's Hospital, London, United Kingdom; Department of Surgery and Cancer, Imperial College, London, United Kingdom.
Ian M FraylingPolyposis Registry, St. Mark's Hospital, London, United Kingdom; Inherited Tumour Syndromes Research Group, Institute of Cancer & Genetics, Cardiff University, United Kingdom.
Sharon E PlonBaylor College of Medicine, Houston, TX; Texas Children's Cancer Center, Texas Children's Hospital, Houston, TX.
Marc GreenblattLarner College of Medicine, University of Vermont, Burlington, VT.
Finlay A MacraeDepartment of Colorectal Medicine and Genetics, Royal Melbourne Hospital, Parkville, Australia; Department of Medicine, University of Melbourne, Parkville, Australia.
Stefan AretzInstitute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany; European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS) - Project ID No 739547.
InSiGHT-ClinGen Hereditary Colon Cancer/Polyposis Variant Curation Expert Panel
Institut d'Investigació Biomédica de Bellvitge · ESThe Royal Melbourne Hospital · AUAmbry Genetics (United States) · USBaylor College of Medicine · USUniversité de Rouen Normandie · FRUniversity of Bonn · DEUniversity of Utah · USEdinburgh Cancer Research · GBGreenwood Genetic Center · USHaukeland University Hospital · NOInstitute of Cancer Research · GBInvitae (United States) · USLeiden University Medical Center · NLLinköping University · SEMedical Genetics Center · DEPeter MacCallum Cancer Centre · AUSaitama Cancer Center · JPSt. Mark's Hospital · USThe University of Melbourne · AUUniversità Cattolica del Sacro Cuore · IT

Funding

Baylor College of Medicine/Stanford University Clinical Genome Resource (CLINGEN)U24HG009649 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI TERI Ellen KLEIN, Aleksandar Milosavljevic · 2021 to 2026
$31.5M
InSiGHT Hereditary Colorectal Cancer/ Polyposis (IHCP)U24CA258119 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI MARC S GREENBLATT, Sean Vahram Tavtigian · 2021 to 2026
$1.1M
Intramural NIH HHSNCI NIH HHS U24 CA258119NHGRI NIH HHS U24 HG009649
6 · The paper itself

Abstract

purposeThe Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel (VCEP) was established by the International Society for Gastrointestinal Hereditary Tumours and the Clinical Genome Resource, who set out to develop recommendations for the interpretation of germline APC variants underlying Familial Adenomatous Polyposis, the most frequent hereditary polyposis syndrome.

methodsThrough a rigorous process of database analysis, literature review, and expert elicitation, the APC VCEP derived gene-specific modifications to the ACMG/AMP (American College of Medical Genetics and Genomics and Association for Molecular Pathology) variant classification guidelines and validated such criteria through the pilot classification of 58 variants.

resultsThe APC-specific criteria represented gene- and disease-informed specifications, including a quantitative approach to allele frequency thresholds, a stepwise decision tool for truncating variants, and semiquantitative evaluations of experimental and clinical data. Using the APC-specific criteria, 47% (27/58) of pilot variants were reclassified including 14 previous variants of uncertain significance (VUS).

conclusionThe APC-specific ACMG/AMP criteria preserved the classification of well-characterized variants on ClinVar while substantially reducing the number of VUS by 56% (14/25). Moving forward, the APC VCEP will continue to interpret prioritized lists of VUS, the results of which will represent the most authoritative variant classification for widespread clinical use.

Indexed as

Adenomatous Polyposis ColiGenetic TestingGenetic VariationGerm CellsGerm-Line MutationHumansACMG/AMP variant classification guidelinesAdenomatous polyposis coli (APC)ClinGenFamilial adenomatous polyposis (FAP)InSiGHT

Identifiers

PMID37800450
PMCPMC10922469
OpenAlexW4387339901

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.